Unicycive Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UNCY and other ETFs, options, and stocks.About UNCY
Unicycive Therapeutics, Inc. is a biotechnology company, which engages in developing novel treatments for kidney diseases. The firm investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S.
UNCY Key Statistics
Stock Snapshot
With a market cap of 209.86M, Unicycive Therapeutics(UNCY) trades at $7.94. The stock has a price-to-earnings ratio of -3.83.
On 2026-06-22, Unicycive Therapeutics(UNCY) stock moved within a range of $6.93 to $8.24. With shares now at $7.94, the stock is trading +14.6% above its intraday low and -3.7% below the session's peak.
Trading volume for Unicycive Therapeutics(UNCY) stock has reached 2.69M, versus its average volume of 1.2M.
The stock's 52-week range extends from a low of $3.71 to a high of $8.74.
The stock's 52-week range extends from a low of $3.71 to a high of $8.74.
UNCY News
While there are already several drugs already approved to treat hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis, Shalabh Gupta isn't...
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.